Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Mesotherapy lacks strong evidence for effectiveness and safety, and its ingredients are not FDA-approved for subcutaneous use.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Most over-the-counter hair loss treatments lack strong evidence of effectiveness and are not FDA-approved.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

The U.S. FDA regulates cosmetics for appearance purposes, but not as strictly as some other countries.

New treatments for child hair loss due to immune issues are effective but not yet officially approved.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

Most Facebook posts about hair loss treatments are promotional and not medically supported, with better quality information found on YouTube.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

The herbal hair oil effectively promotes hair growth, nourishes the scalp, and prevents dandruff.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

Lasers and light treatments are now the most common ways to remove hair.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Some drugs used to treat immune conditions may cause different types of hair loss.

The document concludes that current hair loss treatments have limitations and suggests researching new treatments targeting different factors of hair loss.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.